State of Tennessee Treasury Department Invests $316,000 in Health Catalyst (NASDAQ:HCAT)

State of Tennessee Treasury Department purchased a new position in shares of Health Catalyst (NASDAQ:HCAT) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 10,000 shares of the company’s stock, valued at approximately $316,000.

Other hedge funds have also modified their holdings of the company. Prospera Financial Services Inc acquired a new position in shares of Health Catalyst during the third quarter worth $206,000. Rhumbline Advisers purchased a new stake in Health Catalyst in the third quarter valued at $232,000. Nepsis Inc. purchased a new stake in Health Catalyst in the third quarter valued at $3,101,000. Finally, Conestoga Capital Advisors LLC purchased a new stake in Health Catalyst in the third quarter valued at $3,249,000. 7.28% of the stock is currently owned by institutional investors and hedge funds.

HCAT stock opened at $34.37 on Monday. The stock’s 50-day moving average price is $30.39. Health Catalyst has a 52-week low of $26.00 and a 52-week high of $49.85.

Health Catalyst (NASDAQ:HCAT) last posted its earnings results on Tuesday, November 12th. The company reported ($0.27) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.37) by $0.10. The firm had revenue of $39.40 million for the quarter, compared to analysts’ expectations of $37.77 million. Health Catalyst’s quarterly revenue was up 19.8% on a year-over-year basis. As a group, research analysts predict that Health Catalyst will post -1.14 earnings per share for the current year.

HCAT has been the topic of several recent research reports. Svb Leerink initiated coverage on shares of Health Catalyst in a report on Monday, August 19th. They issued an “outperform” rating and a $55.00 price target on the stock. Leerink Swann initiated coverage on shares of Health Catalyst in a report on Monday, August 19th. They issued an “outperform” rating and a $55.00 price target on the stock. JPMorgan Chase & Co. initiated coverage on shares of Health Catalyst in a report on Monday, August 19th. They issued an “overweight” rating and a $50.00 price target on the stock. Goldman Sachs Group initiated coverage on shares of Health Catalyst in a report on Monday, August 19th. They issued a “buy” rating and a $49.00 price target on the stock. Finally, Evercore ISI initiated coverage on shares of Health Catalyst in a report on Monday, August 19th. They issued an “outperform” rating and a $50.00 price target on the stock. Ten equities research analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and an average target price of $49.33.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services.

Further Reading: What is meant by a buy rating?

Want to see what other hedge funds are holding HCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Health Catalyst (NASDAQ:HCAT).

Institutional Ownership by Quarter for Health Catalyst (NASDAQ:HCAT)

Receive News & Ratings for Health Catalyst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Catalyst and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit